Literature DB >> 15985185

Diagnostic utility of p16 immunocytochemistry for Trichomonas in urine cytology.

Liron Pantanowitz1, Q Jackie Cao, Robert A Goulart, Christopher N Otis.   

Abstract

We present a case in which p16 immunocytochemistry helped establish the diagnosis of Trichomonas in urine from a male patient. Based on this finding, we recommend p16 immunocytochemistry as a diagnostic tool for unexpected patients or specimen types in which potential trichomonads are identified following routine cytologic evaluation.

Entities:  

Year:  2005        PMID: 15985185      PMCID: PMC1183263          DOI: 10.1186/1742-6413-2-11

Source DB:  PubMed          Journal:  Cytojournal        ISSN: 1742-6413            Impact factor:   2.091


Article

We received 50 ml of voided urine from a 84-year-old diabetic male who presented with hematuria. Routine urine cultures yielded no growth after 24 hours. A Papanicolaou-stained ThinPrep™ slide was prepared which revealed benign urothelial cells, neutrophils including "cannonballs" (i.e. neutrophils aggregated around epithelial cells), red blood cells and numerous Trichomonas organisms (Figure 1). The diagnosis of Trichomonas was based upon the presence of a discernible nucleus and cytoplasmic granules that were identified in several of the trichomonads. A visible nucleus and well-defined cytoplasmic granules at 40x magnification are specified as important morphological features required for a confident diagnosis of Trichomonas in liquid-based Pap tests [1]. Although we did not identify flagella in the trichomonads in our case, the finding of flagella, while helpful, is not always required to make a diagnosis of Trichomonas [1]. In fact, the morphologic identification of Trichomonas on liquid-based Pap tests has been shown to be highly accurate [2]. Nevertheless, exfoliated cells including microorganisms in urine are often degenerated, which makes the identification of Trichomonas in these specimens by morphology alone difficult. Therefore, confirmatory testing may be needed. However, traditional methods to detect Trichomonas including culture and wet-mount microscopy, as well as molecular studies, may not always be readily available, particularly on fixed samples received in liquid-based vials for cytologic evaluation.
Figure 1

Group of Trichomonas organisms present in urine (ThinPrep™, Papanicolaou stain).

Group of Trichomonas organisms present in urine (ThinPrep™, Papanicolaou stain). In order to differentiate parasites from degenerated urothelial cells in our case we prepared additional ThinPrep™ slides from the residual specimen to perform immunocytochemistry for cytokeratin (using a cocktail of high- and low-molecular weight keratins) and p16 (using primary purified mouse anti-human p16 antibody, clone G175-405, supplied by BD Biosciences Pharmingen, San Diego, CA, USA). We included p16 based upon recent published data by our group indicating that Trichomonas vaginalis organisms in cervicovaginal specimens are immunoreactive for p16 [3]. In all ten of these cervicovaginal specimens T. vaginalis were p16 positive and demonstrated strong cytoplasmic staining. Immunocytochemical staining for p16, a proven biomarker for high grade dysplasia associated with Human Papillomavirus (HPV) infection, has been previously applied successfully to cervicovaginal cytology specimens [4]. However, p16 immunoreactivity is not specific for HPV-infected epithelium, as immunoreactivity has previously been documented with inflammatory cells, multinucleated giant cells, bacteria and mucus in cervicovaginal specimens [4-6]. It is unclear if p16 staining of Trichomonas organisms reflects specific immunoreactivity (to unknown epitopes) or may be non-specific. In our case, urothelial and squamous cells were strongly immunoreactive for cytokeratin (Figure 2) but were negative for p16, whereas trichomonads demonstrated strong p16 immunoreactivity (Figure 3 and Figure 4) and failed to react with cytokeratin. Appropriate controls were included in this study (data not shown). Following the diagnosis of Trichomonas, our patient was treated with a course of metronidazole.
Figure 2

Cytokeratin immunocytochemistry. A single urothelial cell demonstrates strong cytokeratin immunoreactivity whereas surrounding trichomonads are negative. Degenerated inflammatory cells are also present in this field.

Figure 3

p16 immunocytochemistry. A group of trichomonads demonstrate strong p16 immunoreactivity whereas an adjacent degenerated urothelial cell and squamous cell are negative.

Figure 4

A single trichomonad, adjacent to an unstained exfoliated squamous epithelial cell, is shown to be p16 immunoreactive.

Cytokeratin immunocytochemistry. A single urothelial cell demonstrates strong cytokeratin immunoreactivity whereas surrounding trichomonads are negative. Degenerated inflammatory cells are also present in this field. p16 immunocytochemistry. A group of trichomonads demonstrate strong p16 immunoreactivity whereas an adjacent degenerated urothelial cell and squamous cell are negative. A single trichomonad, adjacent to an unstained exfoliated squamous epithelial cell, is shown to be p16 immunoreactive. Trichomonas infection in male patients may be asymptomatic or associated with non-gonococcal urethritis, prostatitis, and urethral strictures. Protozoa in men may be harbored in the uncircumcised prepuce, urethra, seminal vesicles, prostate gland or bladder. As shown in the present case, it is often difficult to establish the diagnosis of Trichomonas in men, particularly when the diagnosis is based solely on the cytological evaluation of poorly preserved organisms in a urine specimen. The diagnosis may be especially problematic when the patient denies sexual contact, or when a sexually transmitted disease in a particular patient, such as an infant [7] or the elderly, seems implausible. Adding to the problem is the fact that when in urine, trichomonads usually assume variable shapes [8]. Parasite variation in size and shape may be further exaggerated in air-dried urine smears [9]. In male patients, the organisms also tend to be somewhat smaller than their counterpart in female patients [10]. In addition to the present patient, our laboratory has diagnosed Trichomonas in Papanicolaou-stained urine specimens in eight men of mean age 59 years (range 47–82 years), over a 15 year period. This finding is in keeping with published data suggesting that higher organism loads occur in older men [11]. We do not know if any of these individuals also had diabetes. In conclusion, as illustrated in the case presented, we recommend the use of p16 immunocytochemistry to help establish the diagnosis of Trichomonas in unexpected patients or specimen types in which potential trichomonads are identified following routine cytologic evaluation.
  11 in total

1.  Trichomonas vaginalis in urine cytology.

Authors:  C K Loo; S Guné
Journal:  Acta Cytol       Date:  2000 May-Jun       Impact factor: 2.319

2.  Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens.

Authors:  Marluce Bibbo; William J Klump; Jennifer DeCecco; Albert J Kovatich
Journal:  Acta Cytol       Date:  2002 Jan-Feb       Impact factor: 2.319

3.  [Detection of Trichomonas vaginalis in men].

Authors:  E Małyszko; T Januszko
Journal:  Pol Tyg Lek       Date:  1991 Dec 26-30

4.  The Papanicolaou smear as a diagnostic tool in male trichomoniasis.

Authors:  J L Summers; M L Ford
Journal:  J Urol       Date:  1972-05       Impact factor: 7.450

5.  The diagnosis of trichomonas vaginalis in liquid-based Pap tests: morphological characteristics.

Authors:  Deniz L Aslan; Dan M McKeon; Edward B Stelow; H Evin Gulbahce; K Kjeldahl; Stefan E Pambuccian
Journal:  Diagn Cytopathol       Date:  2005-05       Impact factor: 1.582

6.  Trichomonas vaginalis urinary tract infection in an infant.

Authors:  T Schares; S Machtinger; A E D'Harlingue; J R Maloney
Journal:  Pediatr Infect Dis       Date:  1982 Sep-Oct

7.  Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.

Authors:  Anjali Saqi; Theresa L Pasha; Cindy M McGrath; Gordon H Yu; Paul Zhang; Prabodh Gupta
Journal:  Diagn Cytopathol       Date:  2002-12       Impact factor: 1.582

8.  Trichomonas vaginalis P16 Immunoreactivity in cervicovaginal Pap tests: a diagnostic pitfall.

Authors:  Liron Pantanowitz; Roxanne R Florence; Robert A Goulart; Christopher N Otis
Journal:  Diagn Cytopathol       Date:  2005-09       Impact factor: 1.582

9.  Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic.

Authors:  K A Wendel; E J Erbelding; C A Gaydos; A M Rompalo
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

10.  P16INK4a as an adjunct marker in liquid-based cervical cytology.

Authors:  Shaira Sahebali; Christophe E Depuydt; Kurt Segers; Liliane M Moeneclaey; Annie J Vereecken; Eric Van Marck; Johannes J Bogers
Journal:  Int J Cancer       Date:  2004-03-01       Impact factor: 7.396

View more
  2 in total

1.  CytoJournal's move to the new platform: More on financial model to the support open-access charter in cytopathology, publication quality indicators, and other issues.

Authors:  Vinod B Shidham; Martha B Pitman; Richard M Demay; Barbara F Atkinson
Journal:  Cytojournal       Date:  2008-12-16       Impact factor: 2.091

2.  ASC-H in Pap test--definitive categorization of cytomorphological spectrum.

Authors:  Mamatha Chivukula; Vinod B Shidham
Journal:  Cytojournal       Date:  2006-05-10       Impact factor: 2.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.